Luisa Puche - 16 Dec 2021 Form 4/A - Amendment Insider Report for Enochian Biosciences Inc (RENB)

Role
Chief Financial Officer
Signature
/s/ Luisa Puche
Issuer symbol
RENB
Transactions as of
16 Dec 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
11 Jan 2022, 16:54:29 UTC
Date Of Original Report
20 Dec 2021
Previous filing
23 Nov 2021
Next filing
26 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RENB Common Stock Disposed to Issuer $0 -10,000 -100% $0.000000* 0 16 Dec 2021 Direct F1
transaction RENB Common Stock Award $0 +16,266 $0.000000 16,266 16 Dec 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer cancelled the shares of common stock previously issued to Ms. Puche upon the vesting of certain restricted stock units.
F2 Ms. Puche received restricted stock units under the Issuer's 2019 Equity Incentive Plan. 11,266 of the restricted stock units vested on the Grant Date; the remaining 5,000 restricted stock units vested on January 7, 2022. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that have vested.